Stratview Research has published a new report titled Acute Lung Injury Market to its database. It has segmented the market By Therapy (Mechanical Ventilation, Pharmacotherapy, Fluid Management), By End-Use (Hospitals, Clinics, Others), and by Region (North America [The USA, Canada, and Mexico], Europe, and Rest of the World [Brazil, Saudi Arabia, and Others]).

Market Segments' Analysis

The market researchers have studied the Acute Lung Injury Market minutely for better understanding. The report consists of segment-wise details to assist the users in making suitable decisions for better growth opportunities. Below is the short piece of information -

Based on therapy, the acute lung injury market has been classified into mechanical ventilation, pharmacotherapy, and fluid management. The mechanical ventilation segment accounted for the largest market share in 2020, owing to its primary choice for the supportive treatment of patients suffering from acute lung injury (ALI). It includes the delivery of air/oxygen at tidal volumes and frequencies to be enough to reduce the pressure on breathing with simultaneous progress in oxygenation, which further augments the segment growth.

Request a Free Sample here:

Key Players of the market:

  • GlaxoSmithKline plc (UK)
  • INO Therapeutics, LLC (US)
  • Octapharma AG (Switzerland)
  • Ono Pharmaceutical Co., Ltd. (Japan)
  • Eli Lilly and Company (US)
  • Chiesi S. p. A. (Italy)
  • B. Braun Melsungen AG (Germany)
  • Altor BioScience Corporation (US)

In terms of region, the North America Acute Lung Injury market accounted for a significant share in 2020 and is expected to grow at a robust CAGR during the review period. The Acute Lung Injury market growth is mainly propelled by rising prevalence of acute lung injuries in the region. 

Highlights of the report:

The report also highlights the following segments -

-          The market structure and forecasts for the coming years.

-          Drivers, restraints, opportunities, and current trends of Acute Lung Injury Market.

-          Historical data and forecast.

-          Estimations for the forecast period 2028.

-          Developments and trends in the market.

Our market research experts have studied the ACUTE LUNG INJURY Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-chain, pricing trends, product preferences, consumer patterns & more. The findings are further validated through primary research with industry experts across the globe.

Reasons to Invest in this Report:

-          The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period.

-          Segments include quantitative, qualitative, and value data.

-          Regional, and country level data includes the demand and supply forces along with their influence on the market.

-          The competitive landscape comprises share of key players, new developments, and strategies in the last three years.

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.